Table 1 Demographic, clinical, laboratory and radiological characteristics of patients with and without intensive care unit requirement due to COVID-19 disease

Demographic data

Age (median) (min-max)

76(65–96)

75(65–96)

78(65–95)

0.180

Female gender, n (%)

95 (50.5)

75 (50.3)

20 (51.3)

0.916^x

Clinical data

Duration of hospitalisation (days) (Median)(min-max)

12 (3–40)

10 (3–36)

16 (6–40)

< 0.001^m

Presence of oxygen requirement, n (%)

122 (64.9)

88 (59.1)

34 (87.2)

0.001^x

Exitus, n (%)

33 (17.6)

12 (8.1)

21 (53.8)

< 0.001^x

Additional diseases

Hypertension, n (%)

142 (75.5)

112 (75.2)

30 (76.9)

0.820^x

Diabetes Mellitus, n (%)

76 (40.4)

60 (40.3)

16 (41)

0.932^x

COPD:, n (%)

55 (29.3)

42 (28.2)

13 (33.3)

0.529^x

CAD, n (%)

85 (45.2)

65 (43.6)

20 (51.3)

0.392^x

Dementia, n (%)

19 (10.1)

15 (10.1)

4 (10.3)

0.972^x

Hypothyroidism, n (%)

15 (8)

12 (8.1)

3 (7.7)

0.941^f

Chronic renal failure, n (%)

18 (9.6)

12 (8.1)

6 (15.4)

0.166^f

Laboratory data

Lymphocyte (10⁹/L) (Median)(min-max)

920 (160–8210)

960 (160–8210)

800 (330–2770)

0.500^m*

CRP ( gr/L) (median)(min-max)

78 (1-291)

82.6 (1-269)

56.6 (5.5–291)

0.219^m

Procalcitonin (μg/L) (median)(min-max)

0.1 (0–20)

0.1 (0–20)

0.2 (0.03–2.5)

0.019^m

Maximum ferritin level (μg/L) (Median)(min-max)

571 (24-29467)

543 (24-12391)

989 (47-29467)

0.006^m

Lactate (mmol/L) (Median)(min-max)

1.6 (0.02–4.9)

1.6 (0.02–4.9)

1.5 (0.5–3.7)

0.197^m

Maximum interleukin-6 level (pg/mL) (median)(min-max)

571 (24-29467)

26.3 (0.1–759)

33.3 (3.6–1000)

0.048^m

Radiological findings

Right DT (mm) (Mean ± SD)

1.8 ± 0.4

1.7 ± 0.4

2 ± 0.4

0.011^t

Left DT (mm) (Mean ± SD)

1.8 ± 0.4

1.8 ± 0.4

1.8 ± 0.4

0.342^t